Skystar Bio-pharmaceutical Co. (fka SKBI)

[236T568]

So you are presenting 2014 figures?

we are now at the end of 2015 and SKBI has not issued financials since the Sept 2014 10Q


by the way, did you miss the part where the company stated in an 8K in an SEC filing that revenues at its latest quarter DROPPED from $18 million to only $7 million?

Period Ending 30-Sep-14 30-Jun-14 31-Mar-14 31-Dec-13
Total Revenue 18,353 14,240 6,833 9,625
Cost of Revenue 9,590 7,881 4,009 4,906
Gross Profit 8,763 6,359 2,823 4,720

(all numbers times 1000)
Nice q over q growth in gross profit...37.8%.
finance.yahoo.com/q/is?s=skbi